Figure 1.
Selection of patients. ∗Addition of therapeutic drug, switching of anti-TNF-α agent, and dose escalation of anti-TNF-α agent or immunomodulators.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.